DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story

starstarstarstarstar (1)
Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

 

Women's Health Homepage

Study finds bi-annual MR exams better option for young women with genetic risk Annual mammogram may not be necessary

Study finds tomosynthesis is ultimately less expensive than digital mammography Diagnosis-related costs need to be considered

IBM Watson Health unveils breast advisors solution at RSNA Uses imaging analytics

RSNA highlights in digital radiography, fluoroscopy, and mammography Vendors tout advanced applications, AI, security and greater efficiencies

Community practices not abiding by breast cancer screening guidelines for MR High breast density isn't enough

Study finds Transpara deep learning CAD system performs as well as radiologists ScreenPoint solution provides cancer suspicion score from 0 to 100

Volpara brings quality control and better risk assessment to breast imaging Launches two new products as part of VolparaEnterprise platform at RSNA

Siemens unveils its MAMMOMAT Revelation mammography system at RSNA Provides automated breast density measurements at exam

Survey finds most patients prefer annual mammograms Challenges the USPSTF's recommendations

FDA greenlights GE’s SenoBright HD clinical application for breast cancer diagnosis Used to clarify inconclusive screenings

Molecular breast imaging finds cancers that mammograms don't: study

by Lisa Chamoff , Contributing Reporter
Molecular breast imaging (MBI) detected cancer in several women with dense breasts whose mammograms had been negative, with an incremental cancer detection rate of 7.7 per 1,000 screens, a study has found.

The retrospective study, published in the August issue of the American Journal of Roentgenology, examined data from the supplemental screening program at ProMedica Breast Care in Toledo, Ohio, from 2011 to 2014. After having a mammogram, 1,696 women with dense breast underwent supplementary screening with Gamma Medica’s LumaGEM MBI system, which uses the technetium-99m sestamibi radiopharmaceutical and employs a dual-head digital detector and a special collimator. This resulted in the detection of 13 malignancies, after the mammograms read negative for cancer.

Story Continues Below Advertisement

Ask Any Woman. She Wants a Better Breast Imaging Experience.

SoftVue Can Bring It. In today's healthcare environment, a positive patient experience is central in providing excellent patient care. This is where SoftVue comes in - click to read more>>>



“That’s a significant amount of extra cancers,” Dr. Robin Shermis, medical director at the ProMedica Breast Care Center and one of the study’s authors, told HCB News.

The lesion size ranged from .6 to 2.4 centimeters, with a mean of 1.1 centimeters. About 85 percent of the cancers were node negative, which means the prognosis was better.

“We found them early and they would have otherwise gone undetected by mammography,” Shermis said.

The study also found that the positive predictive value (PPV) for recall was 9.1 percent and the PPV for biopsy was 19.4 percent.

Shermis explained that patients at ProMedica Breast Care with a lifetime risk of at least 20 percent for developing breast cancer receive supplementary screening with MR, while patients with dense breast tissue are recommended to receive supplementary screening with MBI.

“MR is a great test, but it’s very expensive and insurance companies won’t pay for it unless you’re high risk,” Shermis said.

MBI delivers almost instantaneous results, he added.

“This new study in the AJR provides further evidence that women with dense breast tissue have more comfortable and less stressful alternatives to standardized secondary screening studies,” said Philip Croxford, chief executive officer of Gamma Medica, in a statement. “These recent clinical results suggest there is a real alternative to the risk of misdiagnosis and unnecessary biopsies.”

The study by ProMedica follows a study by the Mayo Clinic, published in the AJR last year, which found the addition of MBI to mammography increased the invasive breast cancer detection rate 363 percent, from 1.9 to 8.8 per 1,000 screens.

MBI uses 6 to 8 millicuries, about four times the dose from a digital mammogram, though Shermis said it’s possible to cut the dose in half by scanning for twice as long. While some breast cancer experts don’t recommend MBI for annual screening because of the higher dose, Shermis noted that it was important to weigh the risks with the benefit of detecting cancers earlier.

“Six thousand women, who know the benefits and risks, have yet to say ‘I don’t want it,’” Shermis said.

Women's Health Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2017 DOTmed.com, Inc.
ALL RIGHTS RESERVED